SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Bogdanoff who wrote (980)11/22/1997 5:27:00 PM
From: CYBERKEN  Read Replies (1) of 2173
 
The extension doesn't bother me, for the reasons you have stated, and I might get back in if the next set of trial results cast the product in a better light than the last ones did. The extension, however, should make us consider the co's need to raise additional financing and possibly dilute the stock. At this point I just don't see AMLN running away from those of us who are out. Of course, any dip from the 7's would be very enticing!

Finally, the co had begun to emphasize an expansion of it's pipeline when pramlintide was on track. We should be watching to see if that expansion continues to go forward.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News